Humboldt University of Berlin-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2013

  1. Off-Label Use Of Rituximab For Systemic Lupus Erythematosus in Europe: Limited Use Mostly In Refractory Patients

    ARTHRITIS AND RHEUMATISM